Prevalence of Mental Health Disorders Among Adults With Cerebral Palsy: A Cross-sectional Analysis.
Journal
Annals of internal medicine
ISSN: 1539-3704
Titre abrégé: Ann Intern Med
Pays: United States
ID NLM: 0372351
Informations de publication
Date de publication:
03 09 2019
03 09 2019
Historique:
pubmed:
6
8
2019
medline:
11
3
2020
entrez:
6
8
2019
Statut:
ppublish
Résumé
Persons with cerebral palsy (CP) have an increased risk for secondary chronic conditions during childhood, including mental health disorders. However, little is known about how these disorders affect adults with CP. To determine the prevalence of mental health disorders among adults with CP compared with those without CP. Cross-sectional. 2016 Optum Clinformatics Data Mart. 8.7 million adults (including 7348 adults with CP). Other neurodevelopmental comorbid conditions (intellectual disabilities, autism spectrum disorders, epilepsy) and 37 mental health disorders (as 6 categories) were identified on the basis of diagnosis codes. Direct age-standardized prevalence of the mental health disorder categories was estimated by sex for adults with CP alone, adults with CP and neurodevelopmental disorders, and adults without CP. Men with CP alone had higher age-standardized prevalence than men without CP for schizophrenic disorders (2.8% [95% CI, 2.2% to 3.4%] vs. 0.7%), mood affective disorders (19.5% [CI, 18.0% to 21.0%] vs. 8.1%), anxiety disorders (19.5% [CI, 18.0% to 21.0%] vs. 11.1%), disorders of adult personality and behavior (1.2% [CI, 0.8% to 1.6%] vs. 0.3%), and alcohol- and opioid-related disorders (4.7% [CI, 3.9% to 5.5%] vs. 3.0%). The same pattern was observed for women. Compared with adults with CP alone, those with CP and neurodevelopmental disorders had similar or higher age-standardized prevalence of the 6 mental health disorder categories, except for the lower prevalence of alcohol- and opioid-related disorders in men. Single claims code was used to define the cohort of interest. Information on the severity of CP was not available. Compared with adults without CP, those with CP have an elevated prevalence of mental health disorders, some of which may be more pronounced in patients with comorbid neurodevelopmental disorders. National Institute on Disability, Independent Living, and Rehabilitation Research.
Sections du résumé
Background
Persons with cerebral palsy (CP) have an increased risk for secondary chronic conditions during childhood, including mental health disorders. However, little is known about how these disorders affect adults with CP.
Objective
To determine the prevalence of mental health disorders among adults with CP compared with those without CP.
Design
Cross-sectional.
Setting
2016 Optum Clinformatics Data Mart.
Patients
8.7 million adults (including 7348 adults with CP).
Measurements
Other neurodevelopmental comorbid conditions (intellectual disabilities, autism spectrum disorders, epilepsy) and 37 mental health disorders (as 6 categories) were identified on the basis of diagnosis codes. Direct age-standardized prevalence of the mental health disorder categories was estimated by sex for adults with CP alone, adults with CP and neurodevelopmental disorders, and adults without CP.
Results
Men with CP alone had higher age-standardized prevalence than men without CP for schizophrenic disorders (2.8% [95% CI, 2.2% to 3.4%] vs. 0.7%), mood affective disorders (19.5% [CI, 18.0% to 21.0%] vs. 8.1%), anxiety disorders (19.5% [CI, 18.0% to 21.0%] vs. 11.1%), disorders of adult personality and behavior (1.2% [CI, 0.8% to 1.6%] vs. 0.3%), and alcohol- and opioid-related disorders (4.7% [CI, 3.9% to 5.5%] vs. 3.0%). The same pattern was observed for women. Compared with adults with CP alone, those with CP and neurodevelopmental disorders had similar or higher age-standardized prevalence of the 6 mental health disorder categories, except for the lower prevalence of alcohol- and opioid-related disorders in men.
Limitations
Single claims code was used to define the cohort of interest. Information on the severity of CP was not available.
Conclusion
Compared with adults without CP, those with CP have an elevated prevalence of mental health disorders, some of which may be more pronounced in patients with comorbid neurodevelopmental disorders.
Primary Funding Source
National Institute on Disability, Independent Living, and Rehabilitation Research.
Identifiants
pubmed: 31382276
pii: 2747509
doi: 10.7326/M18-3420
pmc: PMC9704040
mid: NIHMS1846891
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
328-333Commentaires et corrections
Type : CommentIn
Références
Bone. 2017 Jan;94:90-97
pubmed: 27732905
Res Dev Disabil. 2016 Feb-Mar;49-50:268-76
pubmed: 26741263
Am J Physiol Endocrinol Metab. 2012 Nov 1;303(9):E1085-93
pubmed: 22912367
Bone. 2018 Sep;114:285-291
pubmed: 29981509
Clin Epidemiol. 2018 May 01;10:511-519
pubmed: 29750055
JAMA Neurol. 2019 Mar 1;76(3):294-300
pubmed: 30592485
Osteoporos Int. 2011 Jan;22(1):37-46
pubmed: 20458577
Dev Med Child Neurol. 2007 Sep;49(9):647-53
pubmed: 17718819
JAMA Pediatr. 2016 Mar;170(3):267-87
pubmed: 26810619
Epilepsy Behav. 2012 Jun;24(2):156-68
pubmed: 22632406
Lancet. 2013 Nov 9;382(9904):1575-86
pubmed: 23993280
Dev Med Child Neurol. 2019 May;61(5):579-585
pubmed: 30362114
Jt Comm J Qual Improv. 2000 Apr;26(4):203-16
pubmed: 10749005
Dev Med Child Neurol. 2018 Jul;60(7):687-694
pubmed: 29667705
Arch Gen Psychiatry. 1998 Jan;55(1):56-64
pubmed: 9435761
Soc Psychiatry Psychiatr Epidemiol. 2012 Nov;47(11):1807-14
pubmed: 22322982
Psychiatr Serv. 2011 Oct;62(10):1159-66
pubmed: 21969642
Muscle Nerve. 2005 May;31(5):594-601
pubmed: 15779003
Bone. 2017 Oct;103:302-307
pubmed: 28720522
JAMA Pediatr. 2018 Sep 1;172(9):795-796
pubmed: 29971353
J Am Acad Child Adolesc Psychiatry. 2008 Aug;47(8):921-9
pubmed: 18645422
Res Dev Disabil. 2011 Nov-Dec;32(6):2829-40
pubmed: 21664797
Lancet Neurol. 2011 Sep;10(9):844-52
pubmed: 21849165
J Intellect Disabil Res. 2018 May;62(5):407-421
pubmed: 29473259
J Bone Miner Res. 2019 Jul;34(7):1240-1247
pubmed: 30730595
Dev Med Child Neurol. 2013 Jun;55(6):509-19
pubmed: 23346889
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):453-464
pubmed: 29392922
J Pediatr. 2009 May;154(5):715-20
pubmed: 19111321
BMC Psychiatry. 2019 Jan 7;19(1):9
pubmed: 30616546
Pediatrics. 2011 Jun;127(6):1034-42
pubmed: 21606152
Int J Obes (Lond). 2019 Jan;43(1):82-90
pubmed: 30181652
Psychol Bull. 2017 Nov;143(11):1155-1200
pubmed: 28805400
Am J Med Genet A. 2015 Aug;167A(8):1830-5
pubmed: 26105013
Dev Med Child Neurol. 2014 Jan;56(1):59-65
pubmed: 24117446
Dev Med Child Neurol. 2018 Jan;60(1):30-38
pubmed: 28914445
Autism. 2014 Oct;18(7):815-26
pubmed: 24353274
Dev Med Child Neurol. 2019 Apr;61(4):484-489
pubmed: 29704244
Am J Med. 2017 Jun;130(6):744.e9-744.e15
pubmed: 28065772
Acad Pediatr. 2014 Sep-Oct;14(5 Suppl):S61-7
pubmed: 24882379
Dev Neurorehabil. 2014 Feb;17(1):64-71
pubmed: 24087974
Eur J Paediatr Neurol. 2016 Mar;20(2):270-274
pubmed: 26748599
Dev Med Child Neurol. 2012 Sep;54(9):836-42
pubmed: 22809436
Obes Rev. 2013 Feb;14(2):171-82
pubmed: 23094988
Res Dev Disabil. 2013 Jan;34(1):72-86
pubmed: 22940161
Dev Med Child Neurol. 2014 Nov;56(11):1059-64
pubmed: 24966011